Showing 1,522 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Deborah Waterhouse: ‘The HIV stigma remains, and this is a battle we’ve got to fight’

Editor's pick
The Guardian
7 February 2022
Pharmaceutical industry

GSK to get $1.25 bln to settle HIV drug patent row with Gilead

Editor's pick
Reuters
2 February 2022
Pharmaceutical industry

CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill

Editor's pick
FierceBiotech
27 January 2022
PrEP policies & guidelines

United States v. Gilead: Two Year Anniversary Letter

Editor's pick
PrEP4All
21 January 2022
HIV treatment

US: Gilead says counterfeiting network sold $250 mln worth of its HIV drugs

Editor's pick
Reuters
19 January 2022
Injectable & long-acting PrEP

Fair Pricing Coalition Welcomes Approval Of Two-Month HIV Prevention Shot; Denounces ViiV Healthcare’s Exorbitant, Unsustainable Pricing

Editor's pick
Fair Pricing Coalition
26 December 2021
Injectable & long-acting HIV treatment

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

GlaxoSmithKline's HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?

Editor's pick
FiercePharma
26 December 2021
New & experimental HIV treatments

Trials of long-acting islatravir for HIV treatment and prevention placed on hold

News
21 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Pharmaceutical industry

'Pharma Bro' firm reaches $40M settlement in gouging case

Editor's pick
Associated Press
9 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
The search for a cure

How Long To An HIV Cure? As GSK Therapy Heads For Human Trials, Where We Are In Fight Against Virus

Editor's pick
News18
1 December 2021
Coronavirus

The New COVID Drugs Are a Bigger Deal Than People Realise

Editor's pick
The Atlantic
29 November 2021
Coronavirus

New licenses could spark manufacture of COVID-19 pills in Africa

Editor's pick
Spotlight
29 November 2021
New & experimental HIV treatments

Gilead and Merck Announce Temporary Pause in Enrolment for Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Islatravir and Investigational Lenacapavir ​​​​​​​

Editor's pick
Gilead Sciences
26 November 2021
Health services & systems

President of Rwanda Urges African Parliaments to Back new African Medicines Agency, the continent's new regulatory authority

Editor's pick
AllAfrica
25 November 2021
Self-testing & home testing

Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd

Editor's pick
GlobeNewswire
24 November 2021
New & experimental HIV treatments

Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo

Editor's pick
FierceBiotech
22 November 2021
Activism & civil society

A Financial Disaster Hits US HIV Agencies in January. Why Won’t Anyone Stop It?

Editor's pick
My Fabulous Disease
16 November 2021
Access to healthcare

African Medicines Agency Treaty Takes Effect – New AMA Agency Should Ease Access to Newer and Safer Medicines

Editor's pick
Health Policy Watch
8 November 2021